Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Norcros maintains expectations after resilient first quarter

(Sharecast News) - Norcros said in an update on Wednesday that it delivered a resilient trading performance in the first quarter of its financial year, with revenue modestly ahead of the prior year and full-year expectations remaining unchanged. In a statement ahead of its annual general meeting, the bathroom products specialist reported that group revenue for the 13 weeks ended 30 June rose 0.6% on a constant currency like-for-like basis, after adjusting for trading days.

Revenue in the core UK and Ireland market increased 1% on a like-for-like basis, supported by continued market share gains in the more resilient mid-premium segment.

In South Africa, revenue was down 0.6% year-on-year, reflecting a difficult start to the quarter, although the group said the closure of the tile manufacturing plant at Johnson Tiles South Africa was completed as planned.

"Norcros continues to grow market share, having delivered another resilient performance during the first quarter," said chief executive Thomas Willcocks.

"Whilst trading conditions remain challenging, we continue to make good progress towards our stated medium-term targets with focused and ongoing execution of our growth strategy."

The London-listed company also reiterated details of its recent agreement to acquire Fibo Holding, a leading provider of waterproof wall panels.

It said the deal was expected to bolster Norcros's European presence and create a dedicated waterproof wall coverings division.

Completion remains subject to approval from the UK Competition and Markets Authority.

At 1242 BST, shares in Norcros were up 1.74% at 292p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.